Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Gut Liver. 2024 Sep 15;18(5):807-813. doi: 10.5009/gnl240006. Epub 2024 Jul 26.
BACKGROUND/AIMS: Lymphoepithelioma-like carcinoma (LELC) is a rare subtype of gastric cancer. We aimed to identify the clinicopathological features and rate of lymph node metastasis (LNM) to investigate the feasibility of endoscopic submucosal dissection for early gastric LELC confined to the mucosa or submucosa.
We compared the clinicopathological characteristics of 116 early gastric LELC patients and 5,753 early gastric well- or moderately differentiated (WD or MD) tubular adenocarcinoma patients treated by gastrectomy.
Compared to WD or MD early gastric cancer (EGC) patients, early LELC patients were younger and had a higher prevalence of proximally located tumors. Despite more frequent deep submucosal invasion (86.2% vs 29.8%), lymphatic invasion was less frequent (6.0% vs 16.2%) in early LELC patients than in WD or MD EGC patients. Among tumors with deep submucosal invasion, the tumor size was smaller, lymphatic invasion was less frequent (6.0% vs 40.2%) and the rate of LNM was lower (10.0% vs 19.4%) in patients with LELC than in those with WD or MD EGC. The overall rate of LNM in early LELC patients was 8.6% (10/116). The risk of LNM in patients with mucosal, shallow submucosal invasive, or deep submucosal invasive LELC was 0% (0/6), 0% (0/10), and 10% (10/100), respectively.
Early LELC is a distinct subtype of EGC with more frequent deep submucosal invasion but less lymphatic invasion and LNM than WD or MD EGCs. Endoscopic submucosal dissection may be considered curative for patients with early LELC confined to the mucosa or shallow submucosa, given its negligible rate of LNM.
背景/目的:淋巴上皮样癌(LELC)是一种罕见的胃癌亚型。我们旨在确定其临床病理特征和淋巴结转移(LNM)率,以探讨内镜黏膜下剥离术(ESD)治疗局限于黏膜或黏膜下的早期胃 LELC 的可行性。
我们比较了 116 例早期胃 LELC 患者和 5753 例接受胃切除术的早期胃高或中分化管状腺癌(WD 或 MD)患者的临床病理特征。
与 WD 或 MD 早期胃癌(EGC)患者相比,早期 LELC 患者更年轻,且近端肿瘤更为常见。尽管深度黏膜下浸润更为常见(86.2% vs. 29.8%),但 LELC 患者的淋巴管浸润更为少见(6.0% vs. 16.2%)。在深度黏膜下浸润的肿瘤中,LELC 患者的肿瘤直径较小,淋巴管浸润较少(6.0% vs. 40.2%),LNM 率较低(10.0% vs. 19.4%)。早期 LELC 患者的总体 LNM 率为 8.6%(10/116)。黏膜、浅黏膜下浸润或深黏膜下浸润的 LELC 患者的 LNM 风险分别为 0%(0/6)、0%(0/10)和 10%(10/100)。
早期 LELC 是一种独特的 EGC 亚型,与 WD 或 MD EGC 相比,其具有更深的黏膜下浸润,但淋巴管浸润和 LNM 较少。鉴于 LNM 发生率极低,对于局限于黏膜或浅黏膜下的早期 LELC 患者,ESD 可能被认为是一种根治性治疗方法。